News Focus
News Focus
icon url

runncoach

11/15/21 11:57 AM

#2628 RE: aCryptoKing #2627

I'm not sure how anything in their filings is anything new. The company has to disclose they are complying with any questions the FDA may have regarding the whistleblower joke and the same with the class actions that end up meaningless. Either way they have created one heck of a trading vehicle as everyone awaits the current trials to fully enroll.
icon url

ranchhand71

11/15/21 7:56 PM

#2630 RE: aCryptoKing #2627

A bit confused crypto— my post was of a positive analyst update. Not a short story. Not paid for news.
So why your comment??
icon url

TheFinalCD

11/17/21 5:20 PM

#2643 RE: aCryptoKing #2627

what a SAVAious mess





November 17, 2021
Cassava Shares Drop Following Report of SEC Investigation
https://www.bloomberg.com/news/articles/2021-11-17/cassava-shares-drop-following-report-of-sec-investigation



November 15, 2021
Cassava Sciences is being investigated by multiple government agencies. Its Alzheimer's drug is the subject of an FDA petition and lawsuits
https://www.businessinsider.com/alzheimers-drugmaker-cassava-sciences-under-investigation-2021-11



November 04, 2021
Evidence of Data Manipulation in Technical Paper Foundational to Cassava Sciences’ Lead Drug Candidate
https://www.globenewswire.com/news-release/2021/11/04/2327702/8339/en/Review-by-Journal-of-Neuroscience-Shows-No-Evidence-of-Data-Manipulation-in-Technical-Paper-Foundational-to-Cassava-Sciences-Lead-Drug-Candidate.html